β-sitosterol alleviated HFD-induced atherosclerosis by regulating the MAPK/Nrf2/NLRP3 pathway in ApoE−/− mice
PLOS One · 18.09.2025 · 20 (9) · e0332990
DOI: 10.1371/journal.pone.0332990 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.09.2025. Verfasst von Weiping Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Lishui People's Hospital, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China. Hauptthemen laut MEDLINE: Sitosterols, NLR Family, Pyrin Domain-Containing 3 Protein, NF-E2-Related Factor 2, Atherosclerosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Background
Atherosclerosis (AS), driven by chronic inflammation and oxidative stress, remains a leading cause of cardiovascular morbidity. While β-sitosterol, a dietary phytosterol, shows therapeutic potential for AS, its mechanisms remain unclear. This study aimed to explore whether β-sitosterol alleviates AS by modulating the MAPK/Nrf2/NLRP3 pathway.
Methods
ApoE −/− mice fed a high-fat diet (HFD) were treated with β-sitosterol for 8 weeks. Lipid profiles, aortic plaque area, oxidative stress markers, and inflammatory mediators were analyzed. Nrf2 pathway activity and NLRP3 inflammasome components were assessed using ELISA, qRT-PCR, and histochemical assays. Results β-sitosterol significantly reduced serum total cholesterol, LDL-C, and aortic plaque area in HFD-fed mice. It suppressed the MAPK pathway and NLRP3 inflammasome activation while downregulating MMP-2/9 expression. Additionally, β-sitosterol activated the Nrf2 pathway, increasing catalase protein (CAT) activity and reducing oxidative stress in liver tissue. However, it showed limited effects on NF-κB, IL-6, IL-10, and certain antioxidants. Conclusion β-sitosterol ameliorates AS by attenuating lipid accumulation, inflammation, and oxidative stress via coordinated regulation of the MAPK/Nrf2/NLRP3 pathways. These findings highlight its potential as a therapeutic agent, though clinical studies are warranted to confirm efficacy and safety in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Lishui People's Hospital, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
- Department of Microbiology, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Jing Jin
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Wu, W., Liu, W., Wu, N., Qu, C., Chu, W., & Jin, J. (2025). β-sitosterol alleviated HFD-induced atherosclerosis by regulating the MAPK/Nrf2/NLRP3 pathway in ApoE−/− mice. PLOS One, 20(9), e0332990. https://doi.org/10.1371/journal.pone.0332990
Vancouver
Wu W, Liu W, Wu N, Qu C, Chu W, Jin J. β-sitosterol alleviated HFD-induced atherosclerosis by regulating the MAPK/Nrf2/NLRP3 pathway in ApoE−/− mice. PLOS One. 2025;20(9):e0332990. doi:10.1371/journal.pone.0332990
BibTeX
@article{Wu2025,
author = {Wu, Weiping and Liu, Wugao and Wu, Ningjun and Qu, Chunsheng and Chu, Weihua and Jin, Jing},
title = {β-sitosterol alleviated HFD-induced atherosclerosis by regulating the MAPK/Nrf2/NLRP3 pathway in ApoE−/− mice},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {9},
pages = {e0332990},
doi = {10.1371/journal.pone.0332990}
}
EUVIMED